Workflow
Tredegar (TG) - 2024 Q1 - Quarterly Results
TGTredegar (TG)2024-05-09 12:23

Financial Performance - First quarter 2024 net income was 3.3million(3.3 million (0.10 per diluted share), compared to a net loss of (1.0)million((1.0) million ((0.03) per diluted share) in Q1 2023[3] - Net income for Q1 2024 was 3,288thousand,comparedtoanetlossof3,288 thousand, compared to a net loss of 1,009 thousand in Q1 2023[45] - For the three months ended March 31, 2024, net income from ongoing operations was 5.6million,comparedto5.6 million, compared to 2.5 million for the same period in 2023, representing a 124% increase[67] - The effective tax rate for Q1 2024 was 16.7%, a significant change from (48.8)% in Q1 2023, due to a shift from a pre-tax loss to pre-tax income[29] - The effective tax rate for net income from ongoing operations was 19.0% for Q1 2024, compared to 34.2% for Q1 2023[64] Sales and Orders - Net new orders for aluminum extruded products increased by 61% in Q1 2024 compared to Q1 2023, marking the sixth consecutive quarterly increase[11] - Total net sales for the three months ended March 31, 2024, were 169.07million,anincreaseof18169.07 million, an increase of 18% compared to the same period in 2023[47] - Net sales decreased by 4.5% to 30,113 thousand in Q1 2024 from 31,527thousandinQ12023,primarilyduetolowersellingpricesandunfavorableproductmix[24]SalesvolumeforFlexiblePackagingFilmsincreasedby10.731,527 thousand in Q1 2023, primarily due to lower selling prices and unfavorable product mix[24] - Sales volume for Flexible Packaging Films increased by 10.7% to 21,973 thousand lbs in Q1 2024 compared to 19,845 thousand lbs in Q1 2023[23] - Surface Protection sales volume increased by 43% in Q1 2024 compared to Q1 2023, indicating a recovery in the consumer electronics market[19] EBITDA and Operational Metrics - EBITDA from ongoing operations for Aluminum Extrusions was 12.5 million in Q1 2024, down from 14.6millioninQ12023,withsalesvolumedecreasingby9.914.6 million in Q1 2023, with sales volume decreasing by 9.9%[6] - PE Films achieved EBITDA of 6.9 million in Q1 2024, significantly up from 1.8millioninQ12023,drivenbya36.21.8 million in Q1 2023, driven by a 36.2% increase in sales volume[20] - EBITDA from ongoing operations rose by 45.4% to 1,963 thousand in Q1 2024, up from 1,350thousandinQ12023[23]ConsolidatedEBITDAfromongoingoperationsforQ12024was1,350 thousand in Q1 2023[23] - Consolidated EBITDA from ongoing operations for Q1 2024 was 17.1 million, up from 13.1millioninQ12023,indicatinga30.613.1 million in Q1 2023, indicating a 30.6% growth[67] Debt and Liquidity - Total debt increased to 148.3 million as of March 31, 2024, up from 146.3millionatDecember31,2023[32]Thecompanyreportedanetdebtof146.3 million at December 31, 2023[32] - The company reported a net debt of 143.5 million as of March 31, 2024, an increase from 132.8millionattheendof2023[64]Thecompanyremainsincompliancewithallcovenantsunderits132.8 million at the end of 2023[64] - The company remains in compliance with all covenants under its 180 million asset-based credit agreement maturing June 30, 2026[34] - The liquidity available under the new asset-based lending facility has met expectations, supporting the company through the downturn[5] Capital Expenditures and Future Projections - Projected capital expenditures for Bonnell Aluminum in 2024 are 9million,including9 million, including 4 million for productivity projects[16] - Capital expenditures for Flexible Packaging Films are projected to be 4millionin2024,withdepreciationexpenseprojectedat4 million in 2024, with depreciation expense projected at 3 million[26] - The company expects depreciation expense of 16millionandamortizationexpenseof16 million and amortization expense of 2 million in 2024[16] Corporate Developments - The company is advancing the sale of Terphane, with the process including reviews by competition authorities in Brazil[5] - The company expects to realize after-tax net debt-free cash proceeds of 85millionfromthepotentialsaleofTerphane,pendingregulatoryapprovals[31]Thecompanyreceived85 million from the potential sale of Terphane, pending regulatory approvals[31] - The company received 47.1 million from the sale of its investment interests in kaléo, with an additional 0.3millionreceivedinJanuary2023[63]CashFlowandWorkingCapitalCashandcashequivalentsdecreasedto0.3 million received in January 2023[63] Cash Flow and Working Capital - Cash and cash equivalents decreased to 3.49 million from 9.66millionattheendofDecember2023[49]Accountsreceivableincreasedto9.66 million at the end of December 2023[49] - Accounts receivable increased to 73.03 million, up from 67.94millionattheendof2023[49]Inventoriesroseto67.94 million at the end of 2023[49] - Inventories rose to 86.82 million, compared to 82.04millionattheendofDecember2023[49]Totalcurrentliabilitiesdecreasedto82.04 million at the end of December 2023[49] - Total current liabilities decreased to 239.43 million from 249.10millionattheendof2023[49]Thecompanyreportedanetcashusedinoperatingactivitiesof249.10 million at the end of 2023[49] - The company reported a net cash used in operating activities of 7.72 million for the quarter, an improvement from $9.11 million in the prior year[51] Operational Focus - The company plans to continue focusing on operational improvements and cost management strategies to enhance profitability moving forward[53] - The company has not included pension expense in calculating EBITDA since 2022, which may affect future financial metrics[66]